NasdaqGS:PGNYHealthcare
A Look At Progyny (PGNY) Valuation After A Steep Three Month Share Price Pullback
Progyny stock performance sets the stage for closer review
Progyny (PGNY) has been under pressure, with the share price showing a 1.5% decline over the past day, a 5.8% decline over the past month, and a 35.5% decline over the past 3 months.
These moves, alongside recent financial figures such as US$1.29b in revenue and US$58.52m in net income, are prompting some investors to reassess what they are paying for the company’s fertility and family benefits business.
See our latest analysis for...